Shire sells cancer drugs to Servier for $2.4B as Takeda circles

Shire said on Monday it would consider returning proceeds from the sale to shareholders through a buyback and that further selective disposals of non-strategic assets were possible.
Canadian firms are having a growing conversation about the need for more homegrown production. from BBC News https://ift.tt/uvTAsct
0 comments:
Post a Comment